It is also worth noting that one of the possible mutations appeared to have a much stronger association with schizophrenia in male populations as opposed to female, probably due to the neuroprotective properties of estrogen
In the United States, where Wegovy and Zepbound carry list prices exceeding $1,000 per month, approximately one in eight adults report currently taking a GLP-1 drugbut this represents a small fraction of the more than 40% of American adults classified as obese [52]
We thought, "Okay, you need a caloric surplus to gain muscle," and "Oh, you need a caloric deficit to lose fat." But what happened in these studies is the recomposition phenomenon, I think 7 out of the 10 studies was a lean mass gain dominant recomposition
Zelniker TA, Wiviott SD, Raz I, et al
The gastric emptying effect is particularly relevant when considering the timing of GLP-1 initiation after surgery